ChiCTR-ONRC-10000909
暂停或中断
/
/
/
2010-06-04
/
/
Chronic obstructive pulmonary disease (COPD)
利用組織多普勒超聲波, 對早期的右心室功能不全, 以及其對左心室功能的影響, 進行一系列的超聲波評估
利用組織多普勒超聲波, 對早期的右心室功能不全, 以及其對左心室功能的影響, 進行一系列的超聲波評估
Serial Echocardiographic Assessment of Early Right Ventricular Dysfunction by Tissue Doppler Echocardiography & its Impact on Left Ventricular Function.
非随机对照试验
Ⅳ期
NA
/
RGC funding for the study
/
75
/
2006-03-27
1990-01-01
/
1) Patients diagnosed with COPD who are stable (without history of acute exacerbation of COPD in the past 3 months before enrolment); and 2) Objective evidence of abnormal and obstructive lung function by spirometry, with FEV1 between 30-80% of normal age-predicted value and FEV1/FVC ratio <70%.；
登录查看1) COPD with history of hospitalization due to acute exacerbation within the past 3 months; 2) COPD who are dependent on assisted ventilation of any kind that may affect cardiac function; 3) Patients who have other interstitial lung disease, e.g. pneumoconiosis, bronchiectasis, alveolar fibrosis, etc; 4) Patients with other active lung pathologies, such as primary or secondary lung malignancies, pneumonia, active tuberculosis, pleural effusion, etc; 5) Patients with primary pulmonary hypertension; 6) Patients with secondary pulmonary hypertension other than due to COPD, such as thromboembolism; 7) Patients who known structural heart disease, such as coronary heart disease, left ventricular hypertrophy, significant valvular heart disease, cardiomyopathies, etc; 8) Patients with active cardiac arrhythmias such as atrial fibrillation; 9) Patients with active systemic illness or end-organ disease that may affect cardiac or pulmonary function, such as renal or liver failure; 10) Patients with disease with expected life expectancy <1 year, such as malignancies; 11) Patients who refuse to participate the study.；
登录查看RGC funding
/
医药时间2024-11-21
新药创始人2024-11-21
细胞与基因治疗领域2024-11-21
细胞与基因治疗领域2024-11-21
细胞与基因治疗领域2024-11-21
细胞与基因治疗领域2024-11-21
药时空2024-11-21
肝脏时间2024-11-21
肝脏时间2024-11-21
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科
